Preclinical studies of ZG19018, a novel irreversible covalent inhibitor of KRAS G12C, for the treatment of advanced nonsmall cell lung cancer and other solid tumors

被引：0
|
作者：
Zhu, Bing
Cui, Dawei
Liu, Ruifeng
Feng, Weidong
Sheng, Zelin
Lv, Binhua
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2790
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2790
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Mixed response to the first-line treatment of KRAS G12C inhibitor, sotorasib, in non-small cell lung cancer: A brief report
    Yang, Jiao
    Huang, Jie
    Yuan, Gongjun
    Lin, Xiao-Cheng
    Chen, Hua-Jun
    Yang, Jin-Ji
    CLINICAL CASE REPORTS, 2024, 12 (06):
  • [22] A phase I/II study of first-in-human trial of JAB-21822 (KRAS G12C inhibitor) in advanced solid tumors.
    Li, Jian
    Zhao, Jun
    Cao, Baoshan
    Fang, Jian
    Li, Xiaoyan
    Wang, Mengzhao
    Ba, Yi
    Li, Xingya
    Li, Zhihua
    Liu, Zhe
    Wang, Yongsheng
    Cheng, Ying
    Bai, Chunmei
    Shen, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [23] Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C-Mutant Non-Small Cell Lung Cancer
    Adachi, Yuta
    Ito, Kentaro
    Hayashi, Yuko
    Kimura, Ryo
    Tan, Tuan Zea
    Yamaguchi, Rui
    Ebi, Hiromichi
    CLINICAL CANCER RESEARCH, 2020, 26 (22) : 5962 - 5973
  • [24] KRAS G12C mutation associated outcomes among patients with locally advanced non-small cell lung cancer.
    Qian, David
    Behera, Madhusmita
    Steuer, Conor Ernst
    Pakkala, Suchita
    Carlisle, Jennifer W.
    Owonikoko, Taofeek Kunle
    Fischer-Valuck, Benjamin Walker
    Kesarwala, Aparna Hemant
    Bradley, Jeffrey
    Curran, Walter J.
    Ramalingam, Suresh S.
    Higgins, Kristin Ann
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] Aurora kinase A inhibition overcomes adaptive resistance to KRAS G12C inhibitor by G1-checkpoint induced apoptosis in KRAS non-small cell lung cancer
    Li, Chendi
    Chang, Jeremy
    Graser, Christopher J.
    Syed, Usman M.
    Nimbalkar, Anahita
    Shen, Yi
    Altschuler, Steve
    Wu, Lani
    Michor, Franziska
    Gong, Xueqian
    Hata, Aaron N.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [26] Aurora kinase A inhibition overcome adaptive resistance to KRAS G12C inhibitor by G1-checkpoint induced apoptosis in KRAS non-small cell lung cancer
    Li, Chendi
    Chang, Jeremy
    Syed, Mohammed U.
    Nimbalkar, Anahita
    Shen, Yi
    Altschuler, Steve
    Wu, Lani
    Gong, Xueqian
    Hata, Aaron
    CANCER RESEARCH, 2023, 83 (07)
  • [27] Liquid biopsy to track KRAS G12C mutation at progressive disease in patients with advanced non-small cell lung cancer (NSCLC)
    De Renzi, G.
    Nicolazzo, C.
    Pisegna, S.
    Belardinilli, F.
    Bottillo, I.
    Grammatico, P.
    Giannini, G.
    Gelibter, A. J.
    Gazzaniga, P.
    ANNALS OF ONCOLOGY, 2021, 32 : S983 - S983
  • [28] Phase 1/2 study of FMC-376 an oral KRAS G12C dual inhibitor in participants with locally advanced unresectable or metastatic solid tumors (PROSPER).
    Keating, Anne Therese
    Papadopoulos, Kyriakos P.
    Hloros, Eleni
    Spira, Alexander I.
    McKean, William Bennion
    Krivoshik, Andrew Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study
    Illini, Oliver
    Fabikan, Hannah
    Hochmair, Maximilian Johannes
    Weinlinger, Christoph
    Krenbek, Dagmar
    Brcic, Luka
    Setinek, Ulrike
    Terbuch, Angelika
    Absenger, Gudrun
    Konjic, Selma
    Valipour, Arschang
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (14)
  • [30] CodeBreaK 200: A Phase 3 Multicenter Study of Sotorasib, a KRAS(G12C) Inhibitor, versus Docetaxel in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Harboring KRAS p.G12C Mutation
    Reck, M.
    Spira, A.
    Besse, B.
    Wolf, J.
    Skoulidis, F.
    Borghaei, H.
    Goto, K.
    Park, K.
    Griesinger, F.
    Font, E. F.
    Boyer, M.
    Barrios, C. H.
    Goss, G.
    Yang, H.
    Obiozor, C.
    Ramalingam, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S29 - S29
12345